No abstract available
MeSH terms
-
Acetamides / therapeutic use
-
Antibodies, Monoclonal / therapeutic use
-
Antimalarials / therapeutic use
-
Artemether, Lumefantrine Drug Combination
-
Artemisinins / therapeutic use
-
Azepines / therapeutic use
-
Benzazepines / therapeutic use
-
Benzhydryl Compounds / therapeutic use
-
Benzyl Alcohol / therapeutic use
-
Benzylamines
-
Cyclams
-
Cyclopropanes / therapeutic use
-
Drug Combinations
-
Drug Therapy / nursing*
-
Drug Therapy / trends*
-
Drug-Related Side Effects and Adverse Reactions
-
Ethanolamines / therapeutic use
-
Everolimus
-
Febuxostat
-
Fluorenes / therapeutic use
-
Fluoroquinolones / therapeutic use
-
Gout Suppressants / therapeutic use
-
Heterocyclic Compounds / therapeutic use
-
Humans
-
Immunosuppressive Agents / therapeutic use
-
Indoles / therapeutic use
-
Lacosamide
-
Milnacipran
-
Oligopeptides / therapeutic use
-
Phenols / therapeutic use
-
Selective Serotonin Reuptake Inhibitors / therapeutic use
-
Sirolimus / analogs & derivatives
-
Sirolimus / therapeutic use
-
Tapentadol
-
Thiazoles / therapeutic use
-
Tolvaptan
-
Triazoles / therapeutic use
Substances
-
Acetamides
-
Antibodies, Monoclonal
-
Antimalarials
-
Artemether, Lumefantrine Drug Combination
-
Artemisinins
-
Azepines
-
Benzazepines
-
Benzhydryl Compounds
-
Benzylamines
-
Cyclams
-
Cyclopropanes
-
Drug Combinations
-
Ethanolamines
-
Fluorenes
-
Fluoroquinolones
-
Gout Suppressants
-
Heterocyclic Compounds
-
Immunosuppressive Agents
-
Indoles
-
Oligopeptides
-
Phenols
-
Serotonin Uptake Inhibitors
-
Thiazoles
-
Triazoles
-
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
-
Febuxostat
-
Tolvaptan
-
Lacosamide
-
fesoterodine
-
golimumab
-
Everolimus
-
besifloxacin
-
silodosin
-
Milnacipran
-
Tapentadol
-
Benzyl Alcohol
-
plerixafor
-
Sirolimus
-
rufinamide